MicroMass Communications launches COVID wellbeing resourceA new online resource that aims to help users build coping skills and support their emotional wellbeing has Share XMicroMass Communications launches COVID wellbeing resourcehttps://pharmaphorum.com/news/micromass-communications-covid-wellbeing/
MicroMass hires Rosanne Johnson as executive vice presidentPharmaceutical marketing agency MicroMass Communications has named Rosanne Johnson as its new executive vice president. In her role, Share XMicroMass hires Rosanne Johnson as executive vice presidenthttps://pharmaphorum.com/sales-marketing/micromass-hires-rosanne-johnson-as-executive-vice-president/
Assessing provider (and patient) motivationBehavioural science provides a roadmap to understanding how HCPs make decisions and what drives prescribing behaviour, but also, Share XAssessing provider (and patient) motivationhttps://pharmaphorum.com/views-and-analysis/assessing-provider-and-patient-motivation/
Encouraging HCPs to ‘stop and think’Healthcare professionals (HCPs) strive to give their patients the best possible care and treatment, but it’s a tough Share XEncouraging HCPs to ‘stop and think’https://pharmaphorum.com/views-and-analysis/encouraging-hcps-to-stop-and-think/
A spotlight on patient-provider dialoguePatient-provider communication impacts both short- and long-term outcomes. Research demonstrates that poor communication leads to distress, uncertainty, internal Share XA spotlight on patient-provider dialoguehttps://pharmaphorum.com/views-and-analysis/behavioural-science-patient-provider-dialogue/
Does your brand need behavioural science?Behavioural science has become a buzzword for pharma. Why? Because behaviour is a barrier to meeting brand objectives. Share XDoes your brand need behavioural science?https://pharmaphorum.com/views-and-analysis/behavioural-science-pharma-brands/
